Bicocca Open Archive

Logo unimib boa
BALLARINI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.262
AS - Asia 6.599
EU - Europa 5.758
SA - Sud America 826
AF - Africa 107
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 12
Totale 22.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.987
SG - Singapore 2.190
CN - Cina 1.556
IT - Italia 1.408
VN - Vietnam 1.306
DE - Germania 1.197
RU - Federazione Russa 859
HK - Hong Kong 718
BR - Brasile 691
SE - Svezia 603
IE - Irlanda 409
GB - Regno Unito 311
UA - Ucraina 210
CA - Canada 185
KR - Corea 134
AT - Austria 132
IN - India 128
FI - Finlandia 126
FR - Francia 114
ID - Indonesia 111
JP - Giappone 97
DK - Danimarca 77
TR - Turchia 75
MX - Messico 63
LT - Lituania 62
PL - Polonia 59
AR - Argentina 56
BD - Bangladesh 53
NL - Olanda 52
ZA - Sudafrica 45
AU - Australia 43
BE - Belgio 41
IQ - Iraq 39
ES - Italia 30
EC - Ecuador 27
IR - Iran 25
EG - Egitto 21
CH - Svizzera 20
MY - Malesia 17
PK - Pakistan 17
SA - Arabia Saudita 17
TW - Taiwan 14
UZ - Uzbekistan 14
VE - Venezuela 14
IL - Israele 13
PY - Paraguay 12
CO - Colombia 10
EU - Europa 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
MA - Marocco 9
RO - Romania 9
CZ - Repubblica Ceca 8
TN - Tunisia 8
CR - Costa Rica 6
KW - Kuwait 6
TH - Thailandia 6
UY - Uruguay 6
AO - Angola 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
JO - Giordania 5
KE - Kenya 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
OM - Oman 5
CL - Cile 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
KG - Kirghizistan 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CU - Cuba 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
Totale 22.602
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.945
Singapore 1.293
Dallas 1.112
Ashburn 840
Frankfurt am Main 807
Hong Kong 703
Milan 568
Chandler 406
Dublin 395
Ho Chi Minh City 389
Wilmington 335
Hanoi 286
Beijing 275
New York 272
Dearborn 259
Woodbridge 248
Los Angeles 200
Houston 194
Fairfield 192
Jacksonville 187
Santa Clara 173
Hefei 168
Princeton 149
Vienna 111
Boardman 109
Shanghai 104
Nanjing 100
Seattle 93
Moscow 90
Munich 84
Jakarta 83
Seoul 81
Guangzhou 78
São Paulo 78
Buffalo 76
Chicago 69
The Dalles 63
Council Bluffs 61
Dong Ket 51
Rome 50
Vilnius 48
Tokyo 44
Toronto 43
Montreal 41
London 40
Cambridge 38
Carate Brianza 38
Denver 38
Saint Petersburg 38
Turku 37
Altamura 36
Haiphong 36
Warsaw 36
Helsinki 35
Brooklyn 34
Nuremberg 34
Rio de Janeiro 34
Shenyang 34
Da Nang 32
Lawrence 32
Lachine 30
Orem 30
Brussels 29
Hải Dương 28
Kent 28
Pune 28
Stockholm 28
Daejeon 27
Jinan 27
Nanchang 27
Ninh Bình 27
Falls Church 26
Fremont 26
Ha Long 26
Johannesburg 26
Ottawa 26
Andover 25
Atlanta 25
Biên Hòa 25
Changsha 25
Poplar 25
Quận Bình Thạnh 25
Kunming 23
Mexico City 23
Phoenix 23
San Jose 23
Chennai 22
Sacramento 22
Bắc Ninh 20
Columbus 20
Florence 20
Thái Nguyên 20
Tianjin 20
Zhengzhou 20
Shangdi 19
Can Tho 18
Hangzhou 18
Lappeenranta 18
Vũng Tàu 18
Ankara 17
Totale 14.478
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 519
CIPN and its mechanism of development 517
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 507
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 486
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 446
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 442
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 421
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 414
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 397
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 393
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 381
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 372
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 356
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 287
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 285
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 282
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 279
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 274
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 272
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 258
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 256
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 254
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 249
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 242
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 239
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 236
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 236
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 236
Histone deacetylases inhibitors: a new frontier for neuroprotection? 232
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 230
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 229
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 227
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 223
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 220
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 218
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 218
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 218
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 217
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 216
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 216
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 215
MSCs effect on Dark Agouti rats affected by chronic EAE 214
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 212
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 209
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 205
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 205
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 205
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 203
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 200
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 197
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 197
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 194
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 193
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 190
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 190
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 188
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 185
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 183
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 182
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 179
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation 178
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 178
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 178
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 177
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 176
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 176
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 170
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 167
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 164
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 162
Nose-to-brain delivery of polymeric nanoparticles 160
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 159
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 150
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 150
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 149
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 140
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 140
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment 136
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 133
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 125
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 124
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 112
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 110
Blood NfL as a potential axonal damage marker in different CIPN rat models. 110
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 93
null 92
MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome 90
null 80
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 79
Totale 23.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.304 0 0 0 0 0 224 223 220 175 146 123 193
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.289 217 531 299 238 208 324 57 105 138 40 63 69
2023/20241.731 59 65 61 119 197 362 307 98 101 47 57 258
2024/20254.837 262 463 436 226 389 210 327 202 551 673 438 660
2025/20267.538 1.881 1.106 1.613 1.198 1.135 605 0 0 0 0 0 0
Totale 23.552